UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$495M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Global Payments
GPN
|
+$400M |
| 4 |
Mastercard
MA
|
+$274M |
| 5 |
Comcast
CMCSA
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSS
Total System Services, Inc.
TSS
|
+$225M |
| 2 |
WP
Worldpay, Inc.
WP
|
+$190M |
| 3 |
Apple
AAPL
|
+$167M |
| 4 |
RHT
Red Hat Inc
RHT
|
+$166M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Financials | 14.07% |
| 3 | Healthcare | 13.13% |
| 4 | Consumer Discretionary | 12.1% |
| 5 | Communication Services | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRUE
2376
DELISTED
TrueCar
TRUE
| $337K | ﹤0.01% |
99,241
+12,859
| +15% | +$57K |
|
2377
American Vanguard Corp
AVD
$68.9M
| $337K | ﹤0.01% |
21,457
+10,935
| +104% | +$161K |
|
2378
Star Group
SGU
$423M
| $335K | ﹤0.01% |
+35,414
| New | +$339K |
|
2379
Cass Information Systems
CASS
$743M
| $334K | ﹤0.01% |
6,178
| – | – |
|
|
SRDX
2380
DELISTED
Surmodics
SRDX
| $333K | ﹤0.01% |
7,277
+1,646
| +29% | +$71.7K |
|
|
QTNT
2381
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $332K | ﹤0.01% |
1,069
+609
| +132% | +$235K |
|
|
VSLR
2382
DELISTED
VIVINT SOLAR, INC.
VSLR
| $332K | ﹤0.01% |
50,734
+17,334
| +52% | +$137K |
|
2383
Puma Biotechnology
PBYI
$454M
| $332K | ﹤0.01% |
30,821
+5,165
| +20% | +$55.8K |
|
2384
Titan Machinery
TITN
$445M
| $332K | ﹤0.01% |
+23,137
| New | +$412K |
|
|
MDR
2385
DELISTED
McDermott International
MDR
| $330K | ﹤0.01% |
163,399
-46,766
| -22% | -$287K |
|
|
WIFI
2386
DELISTED
Boingo Wireless, Inc.
WIFI
| $330K | ﹤0.01% |
29,696
+15,972
| +116% | +$225K |
|
|
NEX
2387
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $329K | ﹤0.01% |
54,371
+7,714
| +17% | +$45.2K |
|
2388
Nicolet Bankshares
NIC
$3.62B
| $328K | ﹤0.01% |
4,931
| – | – |
|
2389
Preferred Bank
PFBC
$1.25B
| $328K | ﹤0.01% |
6,265
| – | – |
|
2390
TETRA Technologies
TTI
$1.26B
| $328K | ﹤0.01% |
163,048
+47,142
| +41% | +$80.9K |
|
2391
Myers Industries
MYE
$1.29B
| $328K | ﹤0.01% |
18,568
| – | – |
|
|
STML
2392
DELISTED
Stemline Therapeutics, Inc.
STML
| $328K | ﹤0.01% |
31,465
+13,678
| +77% | +$179K |
|
|
RRD
2393
DELISTED
RR Donnelley & Sons Co.
RRD
| $324K | ﹤0.01% |
85,951
+21,383
| +33% | +$50.8K |
|
2394
Ingles Markets
IMKTA
$1.67B
| $320K | ﹤0.01% |
8,239
+1,639
| +25% | +$58.1K |
|
|
DERM
2395
DELISTED
Dermira, Inc.
DERM
| $319K | ﹤0.01% |
49,942
+7,444
| +18% | +$62.2K |
|
|
PETQ
2396
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $319K | ﹤0.01% |
11,700
+2,200
| +23% | +$69.6K |
|
2397
Madrigal Pharmaceuticals
MDGL
$11.8B
| $318K | ﹤0.01% |
3,692
+616
| +20% | +$57.8K |
|
2398
SunCoke Energy
SXC
$797M
| $318K | ﹤0.01% |
56,387
+4,200
| +8% | +$30.2K |
|
2399
DXP Enterprises
DXPE
$2.98B
| $316K | ﹤0.01% |
9,100
| – | – |
|
2400
Tucows
TCX
$175M
| $315K | ﹤0.01% |
5,825
+1,351
| +30% | +$70.5K |
|
Similar funds
UBS AM's Q3 2019 Portfolio in Review
As of Q3 2019, UBS AM held 2,935 positions worth $148B, up 5.8% from $140B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM deployed $6.46B of net new capital in Q3 2019, opening 79 new positions and adding to 1,853 existing holdings. Its largest new stake was 10x Genomics: 184,683 shares worth $9.31M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $167M trimmed.
- UBS AM's largest Q3 2019 buy was 10x Genomics: 184,683 shares worth $9.31M.
- UBS AM added most to Alibaba in Q3 2019, an estimated $495M increase.
- UBS AM's biggest Q3 2019 reduction was Apple, cutting an estimated $167M.
- UBS AM fully exited Total System Services, Inc. in Q3 2019, selling an estimated $225M.
- UBS AM's ten largest holdings make up 19% of its $148B portfolio in Q3 2019.
- UBS AM opened 79 new positions and closed 50 in Q3 2019.
- UBS AM's portfolio value rose 5.8% quarter-over-quarter to $148B.
Based on UBS AM's 13F filing for Q3 2019, filed 14 Nov 2019.